These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


661 related items for PubMed ID: 16753365

  • 1. Prognostic significance of bladder tumor history and tumor location in upper tract transitional cell carcinoma.
    Akdogan B, Dogan HS, Eskicorapci SY, Sahin A, Erkan I, Ozen H.
    J Urol; 2006 Jul; 176(1):48-52. PubMed ID: 16753365
    [Abstract] [Full Text] [Related]

  • 2. Prognostic value of lymphovascular invasion in transitional cell carcinoma of upper urinary tract.
    Hong B, Park S, Hong JH, Kim CS, Ro JY, Ahn H.
    Urology; 2005 Apr; 65(4):692-6. PubMed ID: 15833510
    [Abstract] [Full Text] [Related]

  • 3. The impact factors on prognosis of patients with pT3 upper urinary tract transitional cell carcinoma.
    Wu CF, Pang ST, Chen CS, Chuang CK, Chen Y, Lin PY.
    J Urol; 2007 Aug; 178(2):446-50, dicussion 450. PubMed ID: 17561129
    [Abstract] [Full Text] [Related]

  • 4. The outcome of patients on dialysis with upper urinary tract transitional cell carcinoma.
    Wu CF, Chang PL, Chen CS, Chuang CK, Weng HH, Pang ST.
    J Urol; 2006 Aug; 176(2):477-81. PubMed ID: 16813872
    [Abstract] [Full Text] [Related]

  • 5. Lymphovascular invasion and pT stage are prognostic factors in patients treated with radical nephroureterectomy for localized upper urinary tract transitional cell carcinoma.
    Kim DS, Lee YH, Cho KS, Cho NH, Chung BH, Hong SJ.
    Urology; 2010 Feb; 75(2):328-32. PubMed ID: 20018349
    [Abstract] [Full Text] [Related]

  • 6. The prognostic predictors of primary ureteral transitional cell carcinoma after radical nephroureterectomy.
    Li WM, Li CC, Ke HL, Wu WJ, Huang CN, Huang CH.
    J Urol; 2009 Aug; 182(2):451-8; discussion 458. PubMed ID: 19524962
    [Abstract] [Full Text] [Related]

  • 7. Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma.
    Isbarn H, Jeldres C, Shariat SF, Liberman D, Sun M, Lughezzani G, Widmer H, Arjane P, Pharand D, Fisch M, Graefen M, Montorsi F, Perrotte P, Karakiewicz PI.
    J Urol; 2009 Nov; 182(5):2177-81. PubMed ID: 19758662
    [Abstract] [Full Text] [Related]

  • 8. Postoperative radiation therapy in 26 patients with invasive transitional cell carcinoma of the upper urinary tract: no impact on survival?
    Maulard-Durdux C, Dufour B, Hennequin C, Chrétien Y, Vignes B, Droz D, Delanian S, Housset M.
    J Urol; 1996 Jan; 155(1):115-7. PubMed ID: 7490805
    [Abstract] [Full Text] [Related]

  • 9. Oncologic control after open or laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma: a single center experience.
    Rouprêt M, Hupertan V, Sanderson KM, Harmon JD, Cathelineau X, Barret E, Vallancien G, Rozet F.
    Urology; 2007 Apr; 69(4):656-61. PubMed ID: 17445646
    [Abstract] [Full Text] [Related]

  • 10. The protective role of renal parenchyma as a barrier to local tumor spread of upper tract transitional cell carcinoma and its impact on patient survival.
    Park J, Ha SH, Min GE, Song C, Hong B, Hong JH, Kim CS, Ahn H.
    J Urol; 2009 Sep; 182(3):894-9. PubMed ID: 19616243
    [Abstract] [Full Text] [Related]

  • 11. Nephroureterectomy for treating upper urinary tract transitional cell carcinoma: Time to change the treatment paradigm?
    Brown GA, Busby JE, Wood CG, Pisters LL, Dinney CP, Swanson DA, Grossman HB, Pettaway CA, Munsell MF, Kamat AM, Matin SF.
    BJU Int; 2006 Dec; 98(6):1176-80. PubMed ID: 17125474
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Superficial transitional cell carcinoma of the ureteral orifice: higher risk of developing subsequent upper urinary tract tumors.
    Chou EC, Lin AT, Chen KK, Chang LS.
    Int J Urol; 2006 Jun; 13(6):682-5. PubMed ID: 16834642
    [Abstract] [Full Text] [Related]

  • 18. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically.
    Saito K, Kawakami S, Fujii Y, Sakura M, Masuda H, Kihara K.
    J Urol; 2007 Dec; 178(6):2291-6; discussion 2296. PubMed ID: 17936818
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Risk factors for subsequent development of bladder cancer after primary transitional cell carcinoma of the upper urinary tract.
    Matsui Y, Utsunomiya N, Ichioka K, Ueda N, Yoshimura K, Terai A, Arai Y.
    Urology; 2005 Feb; 65(2):279-83. PubMed ID: 15708038
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 34.